Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on Coagulation in cardiac surgical patients

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 3, 2001, Pages 316-321

  Haisch, Günther ^a   Boldt, Joachim ^a   Krebs, Claudia ^a   Suttner, Stephan ^a   Lehmann, Andreas ^a   Isgro, Frank ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Bleeding; Cardiac; HES 130 0.4; Hydroxyethylstarch; Surgery; Thromboelastography; Volume replacement

Indexed keywords

FRESH FROZEN PLASMA; GELATIN; HEPARIN; HEPARIN LYASE; HES 130; HETASTARCH;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; ENZYME INACTIVATION; ERYTHROCYTE; FEMALE; FLUID THERAPY; HEART SURGERY; HUMAN; HYPOVOLEMIA; INTENSIVE CARE UNIT; MALE; MEASUREMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; THROMBOELASTOGRAPHY;

EID: 0034983851     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.23276     Document Type: Article

References (30)

1. Restoration of volume by crystalloids versus colloid after coronary artery bypass: Hemodynamics, lung water, oxygenation, and outcome
2. Volume therapy in cardiac surgery: Does the kind of fluid matter
3. Volume substitution in shock
4. Microcirculatory perfusion during volume therapy
5. Hemorrhage produces depression in microvascular blood flow which persist despite fluid resuscitation
6. The crystalloid versus colloid controvery: Present status
7. Thrombelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery
8. Hydroxyethylstarch: Safe or not?
9. Effects of progressive haemodilution with hydroxyethylstarch, gelatin and albumin on blood coagulation
10. All medium starches are not the same: Influence of hydroxyethyl substitution of hydroxyethylstarch on plasma volume, hemorrheologic conditions, and coagulation
11. Coagulation disorders caused by hydroxyethylstarch
12. Volume replacement and coagulation: A comprehensive review
13. Thromboelastographic coagulation monitoring during cardiovascular surgery with the RoTEG™ coagulation analyzer
14. Compromised blood coagulation: An in vitro comparison of hydroxyethylstarch 130/0.4 and hydroxyetbylstarch 200/0.5 using thromboelastography
15. Plasma volume support in cardiac surgery
16. Intraoperative hetastarch infusion impairs hemostasis after cardiac surgery operations
17. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch
18. Influence of different intravascular volume therapy on platelet function in patients undergoing cardiopulmonary bypass
19. Increased von Willebrand factor after low-molecular-weight hydroxyethylstarch priming solution in cardiopulmonary bypass
20. In vitro effects of different medium molecular hydroxethylstarch solutions and lactated Ringer's solution on coagulation using SONOCLOT
21. The effects of in vitro hemodilution with gelatin, hydroxyethylstarch, and lactated Ringer's solution on markers of coagulation: An analysis using SONOCLOT
22. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography
23. Gelatin use impairs platelet adhesion during cardiac surgery
24. Thromboelastogram reveals hypercoagulability after administration of gelatin solution
25. Changes in specific markers of haemostasis during reduction mammoplasty
26. Preparation for regional anaesthesia induces changes in thromboelastography
27. Extreme hemodilution in rabbits: An in vitro and in vivo thromboelastographic analysis
28. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography
29. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastography assay
30. Assessing platelet and fibrinogen contributing to clot strength using modified thromboelastography in pregnant women